Starpharma Holdings Ltd
ASX:SPL

Watchlist Manager
Starpharma Holdings Ltd Logo
Starpharma Holdings Ltd
ASX:SPL
Watchlist
Price: 0.395 AUD 9.72% Market Closed
Market Cap: 165.2m AUD

Wall Street
Price Targets

SPL Price Targets Summary
Starpharma Holdings Ltd

Wall Street analysts forecast SPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPL is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.

Lowest
Price Target
0.556 AUD
41% Upside
Average
Price Target
0.561 AUD
42% Upside
Highest
Price Target
0.578 AUD
46% Upside
Starpharma Holdings Ltd Competitors:
Price Targets
OMER
Omeros Corp
216% Upside
PHAT
Phathom Pharmaceuticals Inc
57% Upside
086450
Dongkook Pharmaceutical Co Ltd
36% Upside
2005
SSY Group Ltd
30% Upside
HYPE3
Hypera SA
19% Upside
ROG
Roche Holding AG
1% Upside
605507
Guobang Pharma Ltd
20% Upside
PFE
Pfizer Inc
14% Upside

Revenue
Forecast

Revenue Estimate
Starpharma Holdings Ltd

For the last 13 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 6%. The projected CAGR for the next 3 years is 86%.

6%
Past Growth
86%
Estimated Growth
Estimates Accuracy
-52%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Starpharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Starpharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPL's stock price target?
Price Target
0.561 AUD

According to Wall Street analysts, the average 1-year price target for SPL is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.

What is Starpharma Holdings Ltd's Revenue forecast?
Projected CAGR
86%

For the last 13 years the compound annual growth rate for Starpharma Holdings Ltd's revenue is 6%. The projected CAGR for the next 3 years is 86%.

Back to Top